|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1997-7-21
|
|
pubmed:abstractText |
To study the sequential changes in the intestinal absorption of an oral pentose probe, D-xylose, in patients receiving therapy for untreated acute myeloid leukemia (AML), and to correlate these changes to infectious morbidity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2254-61
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9196138-Adolescent,
pubmed-meshheading:9196138-Adult,
pubmed-meshheading:9196138-Aged,
pubmed-meshheading:9196138-Aged, 80 and over,
pubmed-meshheading:9196138-Antineoplastic Agents,
pubmed-meshheading:9196138-Female,
pubmed-meshheading:9196138-Humans,
pubmed-meshheading:9196138-Intestinal Absorption,
pubmed-meshheading:9196138-Leukemia, Myeloid, Acute,
pubmed-meshheading:9196138-Malabsorption Syndromes,
pubmed-meshheading:9196138-Male,
pubmed-meshheading:9196138-Middle Aged,
pubmed-meshheading:9196138-Mycoses,
pubmed-meshheading:9196138-Neutropenia,
pubmed-meshheading:9196138-Remission Induction,
pubmed-meshheading:9196138-Risk Factors,
pubmed-meshheading:9196138-Xylose
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults.
|
|
pubmed:affiliation |
Department of Medicine, University of Manitoba and The Manitoba Cancer Treatment and Research Foundation, Winnipeg, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
